2007
DOI: 10.1007/s00066-007-1763-5
|View full text |Cite
|
Sign up to set email alerts
|

Whole-Brain Radiotherapy with 20 Gy in 5 Fractions for Brain Metastases in Patients with Cancer of Unknown Primary (CUP)

Abstract: Short-course WBRT with 5 x 4 Gy provided similar intracerebral control and survival as longer programs for the treatment of brain metastases in CUP patients. 5 x 4 Gy appears preferable because it is more convenient for patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
15
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 24 publications
(16 citation statements)
references
References 25 publications
1
15
0
Order By: Relevance
“…Brain metastases occur in 20-40% of all cancer patients and are more frequent than primary brain tumors [1,5,[8][9][10]. Whole-brain radiotherapy (WBRT) alone is the most common treatment for these patients resulting in a median survival of < 6 months in most series [11].…”
Section: Introductionmentioning
confidence: 99%
“…Brain metastases occur in 20-40% of all cancer patients and are more frequent than primary brain tumors [1,5,[8][9][10]. Whole-brain radiotherapy (WBRT) alone is the most common treatment for these patients resulting in a median survival of < 6 months in most series [11].…”
Section: Introductionmentioning
confidence: 99%
“…Brain metastases occur in 20-40% of all cancer patients and are more frequent than primary brain tumors [4,10,11,14]. The best available treatment of patients with one to three brain lesions still needs to be clarified.…”
Section: Introductionmentioning
confidence: 99%
“…Author Population Significant prognostic factors Sehouli et al [19] Ovarian cancer, n = 74 KPS, number of brain metastases, histological grade, platinum sensitivity (multivariate) Cohen et al [2] Ovarian cancer, n = 72 Aggressive local treatment Growdon et al [6] Gynaecological cancers, n = 30 Extracranial disease, histology, use of chemotherapy (multivariate) Fokas et al [4] Bladder cancer, n = 62 Extracranial metastases, RPA class Rades et al [15] Bladder cancer, n = 33 Multivariate analysis revealed no significant prognostic factors Tremont-Lukats et al [24] Prostate cancer, n = 103 Adenocarcinoma vs other histology Nonomura et al [12] Testicular germ cell tumours, n = 27 Single brain metastasis (multivariate) Salvati et al [18] Sarcoma, n = 35 KPS, complete en-bloc surgery Rades et al [13] Unknown primary, n = 101 KPS, extracranial metastases, RPA class Bartelt and Lutterbach [1] Unknown primary, n = 47 KPS, surgical resection status (multivariate) Ruda et al [16] Unknown primary, n = 33 Number of brain metastases (multivariate)…”
Section: Tab 3 Prognostic Factors In Patients With Rare or Unknown Pmentioning
confidence: 99%